ISRCTN49676555已完成3 期
A randomised, placebo-control phase III study to assess the safety and efficacy of the MPT64 patch test in the diagnosis of active tuberculosis (TB)
Sequella Inc (USA)0 个研究点目标入组 512 人开始时间: 2005年11月11日最近更新:
适应症
试验速览
- 阶段
- 3 期
- 状态
- 已完成
- 发起方
- 入组人数
- 512
研究概览
简要总结
2018 results in https://pubmed.ncbi.nlm.nih.gov/29862945/ (added 12/01/2021)
研究设计
- 研究类型
- Interventional
入排标准
- 性别
- All
入选标准
- •TB suspects undergoing investigation at selected health centres for pulmonary TB within the National TB Control Programme of Peru.
排除标准
- •1. Age less than 18 or greater than 65
- •2. Inability or unwillingness to provide written informed consent
- •3. Participation in a clinical trial of another investigational product within the preceding 6 months
- •4. Refusal to undergo voluntary counselling and testing for human immunodeficiency virus (HIV) infection
研究者
相似试验
已完成
3 期
A phase III, randomised, controlled trial for the treatment of HIV-associated cryptococcal meningitis: oral fluconazole plus flucytosine or one week amphotericin B-based therapy vs two weeks amphotericin B-based therapyISRCTN45035509St George's University of London (UK)680
已完成
2 期
Phase II/III Oxabact™ StudyISRCTN63711065OxThera IP AB (Sweden)35
终止
3 期
HYMN: a trial comparing hyperthermia and mitomycin chemotherapy with a second BCG treatment, or other standard treatment, for bladder cancer that has come backCancerISRCTN85785327niversity College London (UK)242
已完成
3 期
Tuberculosis child and adolescent multidrug-resistant preventive therapy: TB CHAMP trialISRCTN92634082Stellenbosch University922
已完成
不适用
RAPID study: Rifaximin for preventing relapse of Clostridium associated diarrhoeaISRCTN65163992niversity of Nottingham (UK)151